Recherche-Formation-Expertise

Tel: (+226) 20 97 01 02

Articles publiés

16. 10. 04
posted by: Amadou KABA
Affichages : 1135

Articles publiés

2014

1         Berthe A, Berthe-Sanou L, Konate B, Hien H, Tou F, Somda S, et al. Motivations, gains et pertes des acteurs soutenant les personnes âgées en incapacités fonctionnelles vivant à domicile à Bobo-Dioulasso (Burkina Faso). Rev Gériatrie. 2014;39(2):91–8.

2         Berthé A, Berthé-Sanou L, Somda S, Konaté B, Hien H, Tou F, et al. The key actors maintaining elders in functional autonomy in Bobo-Dioulasso (Burkina Faso). BMC Public Health. 2014 Jul 5;14(1):689.

3         Ilboudo PG, Somda SM, Sundby J. Key determinants of induced abortion in women seeking post abortion care in hospital facilities in Ouagadougou, Burkina Faso. Int J Womens Health. 2014;6:565–72.

4         Zongo I, Somé FA, Somda SAM, Parikh S, Rouamba N, Rosenthal PJ, et al. Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine. PloS One. 2014;9(8):e103200.

5         Sawadogo A, Sanou S, Hema A, Kamboule BE, Kaboré NF, Sore I et al. Syndrome métabolique et risque cardiovasculaire chez des patients sous antirétroviraux à l’hôpital de jour de Bobo-Dioulasso (Burkina Faso).  Bull Soc Pathol Exot. 2014 Aug; 107(3):151-58.

6      Yaya Bocoum Fadima, Belemsaga Danielle, Adjagba Alex, Walker Damian, Kouanda Seni, Tinto Halidou (2014). Malaria prevention measures in Burkina Faso: distribution and households expenditures. International Journal for Equity in Health13:108. DOI: 10.1186/s12939-014-0108-0.

7      Raffaella M. Ravinetto, Muhammed O. Afolabi, Joseph Okebe, Jennifer Ilo Van Nuil, Pascal Lutumba, Hypolite Muhindo Mavoko, (…) Halidou Tinto et al. (2014) Participation in medical research as a resource-seeking strategy in socio-economically vulnerable communities: call for research and action. Tropical Medicine and International Healthdoi:10.1111/tmi.12396.

8      Susana Scott, Petra F Mens, Halidou Tinto, Alain Nahum, Esmée Ruizendaal, Franco Pagnoni et al. (2014). Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial. Trials , 15:340

9      Compaore, S. Gies • B. Brabin, H. Tinto, L. Brabin (2014). ‘‘There is Iron and Iron…’’ Burkinabe` Women’s Perceptions of Iron Supplementation: A Qualitative Study. Matern Child Health J. DOI 10.1007/s10995-014-1443-x

10   Kajungu DK, Erhart A, Talisuna AO, Bassat Q, Karema C, Nabasumba C, (…) Tinto H et al.(2014)Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven african countries. PLoS One.;9(5): | e96388..

11   Sekou Samadoulougou, Fati Kirakoya-Samadoulougou,  Sophie Sarrassat, Halidou Tinto,  Fidèle Bakiono, Issa Nebié et al.(2014) Paracheck® rapid diagnostic test for detecting malaria infection in under five children: a population-based survey in Burkina Faso Malaria Journal.  13:101.

12   Maltha J, Guiraud I, Kaboré B, Lompo P, Ley B, Bottieau E, (…)Tinto H et al. (2014) Frequency of Severe Malaria and Invasive Bacterial Infections among Children Admitted to a Rural Hospital in Burkina Faso. PLOS ONE 9:2 | e89103

13   Jessica Maltha, Issa Guiraud, Palpouguini Lompo, Bérenger Kaboré, Philippe Gillet, Chris Van Geet, Halidou Tinto et al. (2014) Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso. Malaria Journal; 13: 20.

 

2015

1.         Berthe A., L. Berthe-Sanou, B. Konate, H. Hien, F. Tou, S. Somda et al. (2015). "Functional disability in activities of daily living and instrumental or domestic activities of daily living in the elderly living at home in Bobo-Dioulasso (Burkina Faso)." Geriatr Psychol Neuropsychiatr Vieil 13(4): 381-390.

2.       Riot S., C. Herlin, A. Mojallal, I. Garrido, N. Bertheuil, T. Filleron, S. Somda et al.(2015). "A Systematic Review and Meta-Analysis of Double Venous Anastomosis in Free Flaps." Plast Reconstr Surg 136(6): 1299-1311.

3.       Dahourou DL. Observance du traitement antirétroviral de première ligne chez des enfants traités avant l’âge de deux ans et suppression virologique après 12 mois de traitement dans la cohorte MONOD ANRS 12206, en Afrique de l’Ouest (Côte d’Ivoire et Burkina Faso). Rev d’Épidémiologie Santé Publique. 2015 Jun;63(3):217.

4.       Haoua Tall, Seydou Yaro, Hervé B. N. Kpoda, Soumeya Ouangraoua, Caroline L. Trotter.,Berthe-Marie Njanpop Lafourcade et  al. Meningococcal Seroepidemiology One Year after the PsA-TT Mass Immunization Campaign in Burkina Faso. Clinical Infectious Diseases 2015 Nov 15:61

5.       Traore IT, Meda N, Hema NM, Ouedraogo D, Some F, Some R, et al. HIV prevention and care services for female sex workers: efficacy of a targeted community-based intervention in Burkina Faso. J Int AIDS Soc. 2015;18(1):20088.

6.       Chas J, Hema A, Slama L, Kaboré NF, Lescure FX, Fontaine C et al.. The Day-Hospital of the University Hospital, Bobo-Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso. PloS one [2015, 10(5):e0125588]

7.       Bationo JF, Nikiéma PA, Koudougou K, Ouédraogo M, Bazié SR, Sanou E et al. 2015. Assessment of aflatoxin B1 and ochratoxin A levels in sorghum malts and beer in Ouagadougou. AJFS, Vol. 9(7), pp. 417-420.

8.       Paul SONDO, Bihoun Biebo, Innocent Valéa, Hermann Sorgho, Adama Kazienga, (…) Halidou Tinto (2015): La part du paludisme dans les maladies fébriles en saison sèche dans la région de Nanoro, Burkina Faso. West African Journal of research for health, Vol. (004) 29-32.

9.       K. M. Drabo, G. Sondjo, H. Hien, H. Tinto, M. Traoré, I. Valéa et al. (2015).Prise en charge communautaire du paludisme chez la femme enceinte au Bénin, au Burkina Faso et en Gambie :une revue systématique de littérature. Revue Science et Technique, série sciences de la santé. 38 (N°1 et 2) : 73-81.

10.    K. M. Drabo, H. Tinto, H. Hien, S. Konfé, F. Nana, A. Ly, T. L. Ouédraogo (2015). Perceptions des femmes enceintes fréquentant la consultation prénatale dans les centres de santé de premier échelon du District sanitaire de Do et Dafra au Burkina Faso. Revue Science et Technique, série sciences de la santé. 38 (N°1 et 2) : 21-28.

11.    Tinto H, Sevene E, Dellicour S, Calip GS, d'Alessandro U, (…) Valea I et al. (2015) Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Reprod Health.12(1):112. doi: 10.1186/s12978-015-0101-0.

12.    Halidou Tinto, Olivier Sombié, Innocent Valea, Ferdinand Lankoandé, Sandrine Yara, Palpouguini Lompo et al.(2015) Field evaluation of SD Bioline Malaria Antigen P.f® for Plasmodium falciparum malaria diagnosis in Nanoro, Burkina Faso. Afr. J. Parasitol. Res. 4 (11): 161-165

13.    Neafsey DE, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A, (…)Tinto H, et al. (2015) Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med.373(21):2025-37. doi: 10.1056/NEJMoa1505819.

14.    Tahita MC, Tinto H, Erhart A, Kazienga A, Fitzhenry R, VanOvermeir C et al. (2015) Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-PyrimethaminePLoS One.10(9):e0137440. doi: 10.1371.

15.    Held J, Supan C, Salazar CL, Tinto H, Bonkian LN, Nahum A et al.(2015)Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomized, double-blind, dose-ranging, non-inferiority study. Lancet Infect Dis. pii: S1473-3099(15)00079-1. doi: 10.1016/S1473-3099(15)00079-1.

16.    Andonaba J.B., Konaté I., Diallo B., Sanagré I., Meda N., Zoungrana J., Kafando C., Sawadogo G., Bationo J.F., Sawadogo Y., Dabiré K.R., Taoré A. (2016). La lesihmaniosecutannée, un deuxième foyer épidémique à Leishmania major au Burkina Faso. Annales de Dermatologie et Venerologie., 14” (4) 1 PS24

17.    White MT, Verity R, Griffin JT, Asante KP, Owusu-Agyei S, Greenwood B, (…)Tinto H, Valea I et al. (2015)Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomized controlled trial. Lancet Infect Dis. pii: S1473-3099(15)00239-X. doi: 10.1016/S1473-3099(15)00239-X.

18.    Sondo P, Derra K, Diallo-Nakanabo S, Tarnagda Z, Zampa O, Kazienga A, Valea I (…)Tinto H. (2015)Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial. Malar J.14(1):325. doi: 10.1186/s12936-015-0843-8.

19.    Marc C Tahita, Halidou Tinto, Sibiri Yarga, Adama Kazienga, Maminata Traore/Coulibaly, Innocent Valea et al. (2015) Ex vivo antimalarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso. Malar J :14:251.

20.    Paul Sondo, Karim Derra, Zekiba Tarnagda, Seydou Diallo Nakanabo, Odile Zampa, Adama Kazienga, Innocent Valea,(…)Halidou Tinto (2015) Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso. Pan African Medical Journal; 21:101 doi:10.11604/pamj.2015.21.101.6437.

21.    Tiono AB, Tinto H, Alao MJ, Meremikwu M, Tshefu A, Ogutu B et al.(2015) Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®). Malar J. 14(1):157. doi: 10.1186/s12936-015-0682-7.

22.    Baiden R, Oduro A, H Tinto, Gyapong M, Sie A, Macete E, (…) Valea I et al. (2015) Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and TanzaniaMalar J. 14(1):160. doi: 10.1186/s12936-015-0664-9

23.    Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK et al. (2015). In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso. Antimicrob Agents Chemother 59:734-7. doi: 10.1128/AAC.03647-14.

24.    Nambozi M, Mulenga M, Halidou T, Tagbor H, Mwapasa V, Phiri LK, (…)Valea Iet al.(2015).Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial Reprod Health. 15;12:5. doi: 10.1186/1742-4755-12-5.

25.    Low A, Nagot N, Konate I, Meda N, Segondy M, Van de Perre P, Mayaud P, Vickerman P. Potential impact of existing interventions and of antiretroviral use in female sex workers on transmission of HIV in Burkina Faso: a modeling study.J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S180-8.

 

2016

1         Jesson J, Dahourou DL, Renaud F, Penazzato M, Leroy V. Adverse events associated with abacavir use in HIV-infected children and adolescents: a systematic review and meta-analysis. Lancet HIV. 2016 Feb;3(2):e64–75.

2         Traore IT, Hema NM, Sanon A, Some F, Ouedraogo D, Some R, et al. HIV risk and behavior among part-time versus professional FSW: baseline report of an interventional cohort in Burkina Faso. Sex Transm Infect. 2016 Feb 1.

3         Dahourou DL, Amorissani-Folquet M, Coulibaly M, Avit-Edi D, Meda N, Timite-Konan M, et al. Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013. J Int AIDS Soc [Internet]. 2016 Mar 23 [cited 2016 Aug 20];19(1). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808141/

4         Bekara F, Herlin C, Somda S, de Runz A, Grolleau JL, Chaput B. Free versus perforator-pedicled propeller flaps in lower extremity reconstruction: What is the safest coverage? A meta-analysis. Microsurgery. 2016 Mar 1;n/a – n/a.

5         Poda A, Hema A, Konaté A, Kaboré F, Zoungrana J, Kamboulé E, Soré I et al. Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study. Pan Afr Med J. 2016 Mar 16;23:105.

6         Cabarrou B, Belin L, Somda SM, Falcou MC, Pierga JY, Kirova Y, et al. Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer. Breast Cancer Res Treat. 2016 Apr 13;1–9.

7         Chaput B, Vergez S, Somda S, Mojallal A, Riot S, Vairel B, et al. Comparison of Single and Double Venous Anastomoses in Head and Neck Oncologic Reconstruction Using Free Flaps: A Meta-Analysis. Plast Reconstr Surg. 2016 May;137(5):1583–94.

8         Somda SMA, Florence D, Leconte E, Filleron T. Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approach. Urol Oncol Semin Orig Investig. 2016 May;34(5):244–5.

9         Somda SM, Culine S, Chevreau C, Fizazi K, Leconte E, Kramar A, et al. A statistical approach to determine the optimal duration of post-treatment follow-up: application to metastatic nonseminomatous germ cell tumors. Clin Genitourin Cancer [Internet]. 2016.

10     Coulibaly M, Thio E, Yonaba C, Ouédraogo S, Meda N, Kouéta F,(…), Dahourou DL, et al. Prevention and care of paediatric HIV infection in Ouagadougou, Burkina Faso: knowledge, attitudes and practices of the caregivers. BMC Pediatr. 2016;16:33.

11     Ouedraogo AS, Sanou M, Kissou A, Sanou S, Solaré H, Kaboré F et al. High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016 Jul 11;16:326.

12     Ouedraogo SM, Zoungrana J, Sondo A, Kyelem CG, Koussé S, Hema A, Kaboré FN et al. Dissociation immuno-virologique chez les patients infectés par le VIH-1 sous traitement antirétroviral à l’Hôpital de jour de Bobo-Dioulasso de 2008 à 2012 (Burkina Faso). RAFMI - 2016 ; 3(1) : 17-23.

13     Kuijpers LM, Maltha J, Guiraud I, Kaboré B, Lompo P, Devlieger H, (…)Tinto Het al.(2016)Severe anaemia associated with Plasmodium falciparum infection in children: consequences for additional blood sampling for researchMalar J.15:304. doi: 10.1186/s12936-016-1356-9.

 

14     Kiemde F, Spijker R, Mens PF, Tinto H, Boele M, Schallig HD (2016) Etiologies of non-malaria febrile episodes in children under 5 years in sub-Saharan Africa. Trop Med Int Health. doi: 10.1111/tmi.12722.

15     Halidou Tinto, Innocent Valea, Jean-Bosco Ouédraogo, Tinga Robert Guiguemdé (2016) Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina Faso. Annals of Parasitology 2016, 62(1), 17–24.

16     Halidou Tinto, Constant Sirima, Adama Kazienga, Olivier Sombié, Sandrine Yara, (…)Innocent Valea (2016) Selection of Plasmodium falciparum Pfmdr-1 N86Y alleles by Amodiaquine-Artesunate and Artemether-Lumefantrine in Nanoro, Burkina Faso.J. Parasitol. Vector Biol. 8(2):10-14.

17     PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I et al.(2016) Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med. 2016 Mar 10;374(10):913-27.

18     Derek S. Sarovich, Benoit Garin, Birgit De Smet, Mirjam Kaestli, Mark Mayo, Peter Vandamme, (…)Halidou Tinto et al.(2016).Phylogenomic Analysis Reveals an Asian Origin for African Burkholderia pseudomallei and Further Supports Melioidosis Endemicity in Africa. M Sphere Vol (1) 2. 

19     Decuypere S, Maltha J, Deborggraeve S, Rattray NJ, Issa G, Bérenger K,(…)Tinto H et al.(2016)Towards Improving Point-of-Care Diagnosis of Non-malaria Febrile Illness: A Metabolomics Approach.PLoS Negl Trop Dis. 10(3):e0004480.

20     Decuypere S, Meehan CJ, Van Puyvelde S, De Block T, Maltha J, Palpouguini L, (…) Tinto Het al. (2016). Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach.PLoS Negl Trop Dis.;10(2):e0004470.

21     Brabin BJ, Gies S, Owens S, Claeys Y, D'Alessandro U, Tinto H et al. (2016). Perspectives on the design and methodology of periconceptional nutrient supplementation trials. Trials;17(1):58.

22     Adjei A, Narh-Bana S, Amu A, Kukula V, Nagai RA, Owusu-Agyei S, (…)Halidou Tinto, (…) Valea Iet al.. (2016) Treatment outcomes in a safety observational study of dihydroartemisinin / piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries. Malar J. 2016 15(1):43..

23     Paul Sondo, Karim Derra, Seydou Diallo Nakanabo, Zekiba Tarnagda, Adama Kazienga, Odile Zampa, Innocent Valéa, (…)Halidou Tinto. Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso. PLOS ONE 2016, doi:10.1371/journal.pone.0151565.

24     T.T.E. Dah, J. Orne-Gliemann, J.B. Guiard-Schmid, R. Becquet, J. Larmarange. Les hommes qui ont des rapports sexuels avec d’autres hommes (HSH) et l’infection à VIH à Ouagadougou, Burkina Faso : connaissances, attitudes, pratiques et enquête de séroprévalence. Revue d'Épidémiologie et de Santé Publique, Volume null, Issue null, Page null(In Press)